Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (351-360 of 400) with videos related to

Pageof 40
Sort By:
Annals of Nuclear Medicine|August 16, 2018
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implicationsRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
Molecular imaging for early prediction of response to Sorafenib treatment in sarcomaZhoulei Li, Ken Herrmann, Sabine Pirsig, et al.
Clinical Nuclear Medicine|March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTChristina Bluemel, Markus Krebs, Bülent Polat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2019
<sup>68</sup>Ga-PSMA I&T PET/CT for primary staging of prostate cancerWojciech Cytawa, Anna Katharina Seitz, Stefan Kircher, et al.
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.
Molecular Imaging and Biology|July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2026
Molecular imaging of lymphatic organs provides prognostic value after acute myocardial infarctionTheresa Reiter, Anna-Lena Dörrler, Natalie Hasenauer, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2007
Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaquesB Neumaier, S Deisenhofer, D Fürst, et al.
Cell Reports|May 25, 2022
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodiesAdrian S Enriquez, Tierra K Buck, Haoyang Li, et al.
Pageof 40

Showing results (351-360 of 400) with videos related to

Sort By:
Pageof 40
Annals of Nuclear Medicine|August 16, 2018
Molecular imaging reporting and data systems (MI-RADS): a generalizable framework for targeted radiotracers with theranostic implicationsRudolf A Werner, Ralph A Bundschuh, Lena Bundschuh, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 1, 2014
Molecular imaging for early prediction of response to Sorafenib treatment in sarcomaZhoulei Li, Ken Herrmann, Sabine Pirsig, et al.
Clinical Nuclear Medicine|March 15, 2016
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CTChristina Bluemel, Markus Krebs, Bülent Polat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 19, 2019
<sup>68</sup>Ga-PSMA I&T PET/CT for primary staging of prostate cancerWojciech Cytawa, Anna Katharina Seitz, Stefan Kircher, et al.
Theranostics|May 23, 2017
Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative ApproachRudolf A Werner, Alexander Weich, Takahiro Higuchi, et al.
Cancer Research|November 17, 2006
Molecular imaging of proliferation in malignant lymphomaAndreas K Buck, Martin Bommer, Stephan Stilgenbauer, et al.
Molecular Imaging and Biology|July 18, 2018
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide TherapyRudolf A Werner, Harun Ilhan, Sebastian Lehner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 11, 2026
Molecular imaging of lymphatic organs provides prognostic value after acute myocardial infarctionTheresa Reiter, Anna-Lena Dörrler, Natalie Hasenauer, et al.
Nuklearmedizin. Nuclear Medicine|December 18, 2007
Radiosynthesis and evaluation of [11C]BTA-1 and [11C]3'-Me-BTA-1 as potential radiotracers for in vivo imaging of beta-amyloid plaquesB Neumaier, S Deisenhofer, D Fürst, et al.
Cell Reports|May 25, 2022
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodiesAdrian S Enriquez, Tierra K Buck, Haoyang Li, et al.
Pageof 40